Single User License, Team License, Corporate License
Published January 8, 2018
The Spain OTC drugs market was valued at USD XX million in 2018 and is projected to reach a value of USD XX million by 2024, registering a CAGR of XX%, during the forecast period 2018-2024. Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional.
Spain Over-the-Counter (OTC) Drugs Market Share:
Compared to the past years, Over-the-Counter devices have undergone a predominant change in the markets of Spain. The Product Type segment is expected to have the highest growth rate.
Spain Over-the-Counter (OTC) Drugs Market Size:
There is the full range of Products in Over-the-Counter Drugs Market such as Cough and Cold, Vitamin, Minerals and Supplements, Analgesics, and Digestive Products. As there are significant applications, the market size related to OTC is, even more, more prominent in Spain.
Spain Over-the-Counter (OTC) Drugs Market Growth:
Product Innovation, Increasing distribution channels for OTC drugs, Pharmaceutical companies switching to OTC from Rx drugs, Ease in advertising restrictions for these OTC drugs are significant factors that propel or drive the growth of Spain Over-the-Counter(OTC) Drugs market.
Spain Over-the-Counter (OTC) Drugs Market Industry Analysis:
The Spain Over-the-Counter Drugs market has been segmented by product type, which is sub-segmented into digestive products, vitamins, minerals and supplements, analgesics, cough and cold, and others.
Spain Over-the-Counter (OTC) Drugs Market Outlook:
Incorrect self-diagnosis and Concerns regarding the probability of substance abuse of OTC drugs are the two major factors responsible for the hampering of the OTC market growth.
Spain Over-the-Counter (OTC) Drugs Market Trends:
Takeda and Denali Therapeutics Collaborates to Develop and Commercialize Therapies for Neurodegenerative Diseases. MEDA launched a new product CB12.It is a powerful, unique and patented mouth rinse that ensures not only first-class breath but also provides a daily shot of confidence. Every day and all day CB12 offers 12 hours of protection.
Spain Over-the-Counter (OTC) Drugs Market Research report includes:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Product
6.1 Cough and Cold
6.3 Vitamin, Minerals, and Supplements
6.4 Digestive Products
Chapter 7 Market Segmentation, By Geography
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles
9.1. Johnson & Johnson
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiative
9.2. Takeda Pharmaceutical Company Ltd.
9.3. Reckitt Benckiser Group PLC
9.4. GlaxoSmithKline PLC
9.5. Pfizer, Inc.
9.6. Sanofi S.A.
9.8. Novartis International AG
9.13. Rovi Contract Manufacturing
9.14. Grifols International, S.A.
Chapter 10 Market Estimates and Forecast
10.1 Market Estimates and Forecast 2018-2024(USD Million)
10.1.1 Market Estimation and Forecast by Type2018-2024 (USD Million)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures